Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy

Comment

Saqib Mumtaz et al. Am J Gastroenterol. 2011 Sep.

. 2011 Sep;106(9):1718; author reply 1718-9.

doi: 10.1038/ajg.2011.221.

No abstract available

Comment in

Is the lymphoma risk reduced in viral hepatitis? A cirrhotic patient with triple malignancies.
Doganay L, Kiziltas S, Colak Y, Gulluoglu M, Tuncer I. Doganay L, et al. Am J Gastroenterol. 2011 Sep;106(9):1719-20; author reply 1720. doi: 10.1038/ajg.2011.214. Am J Gastroenterol. 2011. PMID: 21897412 No abstract available.

Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
Les I, Doval E, García-Martínez R, Planas M, Cárdenas G, Gómez P, Flavià M, Jacas C, Mínguez B, Vergara M, Soriano G, Vila C, Esteban R, Córdoba J. Les I, et al. Am J Gastroenterol. 2011 Jun;106(6):1081-8. doi: 10.1038/ajg.2011.9. Epub 2011 Feb 15. Am J Gastroenterol. 2011. PMID: 21326220 Clinical Trial.